Lucence was founded by Dr. Min-Han Tan in 2016 to solve the most complex diagnostic problems in medicine through innovative technology. A world leader in medicine, Dr. Tan’s research has spanned diverse fields of clinical medicine, human genetics and medical data analytics to regularly rewrite orthodoxy. He is recognized internationally for his landmark discovery of the circulating tumor-endothelial cell clusters in the blood of cancer patients, which overturned a 50-year scientific dogma and led to a new way of looking at cancer.
Infused with the same DNA of relentless innovation, Lucence is focused on delivering advanced cancer diagnostic tests to improve cancer care. Our team consists of physicians, scientists, technologists, geneticists, bioinformaticians and data analysts who are committed to fighting cancer.
Lucence was founded by Dr. Min-Han Tan in 2016 to solve the most complex diagnostic problems in medicine through innovative technology. A world leader in medicine, Dr. Tan’s research has spanned diverse fields of clinical medicine, human genetics and medical data analytics to regularly rewrite orthodoxy. He is recognized internationally for his landmark discovery of the circulating tumor-endothelial cell clusters in the blood of cancer patients, which overturned a 50-year scientific dogma and led to a new way of looking at cancer.
Infused with the same DNA of relentless innovation, Lucence is focused on delivering advanced cancer diagnostic tests to improve cancer care. Our team consists of physicians, scientists, technologists, geneticists, bioinformaticians and data analysts who are committed to fighting cancer.
